COMPANY

Laguna Biotherapeutics

HQ: Berkeley, CA source · lagunabio.com ↗

Laguna Biotherapeutics is a biotechnology company developing attenuated microbial platforms that activate the combination of signals required for T cells to find and kill cancer. From company website Source · checked 2026-10-19

Sources for this description (1)

Laguna Biotherapeutics is a biotechnology company developing attenuated microbial platforms that activate the combination of signals required for T cells to find and kill cancer.
- “Laguna is a biotechnology company developing next-generation attenuated microbial platforms that have the predictable PK/PD of small molecule drugs and activate the precise combination of signals required for T cells to find and kill cancer.” https://www.lagunabio.com/about (2026-10-19)

Keywords: oncology cancer Acute Leukemia Myelodysplastic Syndrome QUAIL-100

Location: Berkeley, CA · source · Oct 28, 2022

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

2026-08 Trial start Phase 1: Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation source ↗

Upcoming milestones

2028-06 (ESTIMATED) · Phase 1 · Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation · NCT07573111

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07573111	Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation	Phase 1	Recruiting	2026-08	2028-06 (estimated)